PLENARY KEYNOTE SESSIONS
Monday, May 12 | 4:25 – 5:10 PM
The Role of Protein Engineering in Developing New Innovative Modalities
Puja Sapra, PhD, Senior Vice President, Head R&D Biologics, Engineering and Oncology Targeted Discovery, AstraZeneca
5:10 – 5:55 PM
PEGS 2025 YOUNG SCIENTIST KEYNOTE
Antibody-Lectin Chimeras for Glyco-Immune Checkpoint Blockade
Jessica C. Stark, PhD, Underwood-Prescott Career Development Professor, MIT
Wednesday, May 14 | 8:50 – 9:35 AM
Ex vivo and in situ Engineered Stroma Targeted CAR T Cells for the Treatment of Solid Tumors and Fibrosis
Ellen Puré, PhD, Chair & Professor, Biomedical Sciences, University of Pennsylvania
Thursday, May 15 | 11:35 AM - 12:25 PM
Plenary Fireside Chat: Riding the Next Biotech Wave—Trends in Biotech Investments, Partnering, and M&As
Moderator:
Jakob Dupont, MD, Executive Partner, Sofinnova Investments
Panelists:
Michal Preminger, PhD, MBA, Regional Head, East North America, Johnson & Johnson Innovation LLC
Shyam Masrani, Partner, Medicxi
Uciane Scarlett, PhD, former Principal, MPM Capital
Anthony B. Barry, PhD, Executive Director, ES&I Lead, Biotherapeutics, Technologies, and Digital, Pfizer Inc.